Receptor activator of nuclear factor-kB ligand (RANKL) and bone mineral density in Tunisian patients with chronic obstructive pulmonary disease (COPD)
M. Mjid (Tunis, Tunisia), L. Laadhar (Tunis, Tunisia), A. Taboubi (Tunis, Tunisia), I. Ayadi (Tunis, Tunisia), A. Hedhli (Tunis, Tunisia), Y. Ouahchi (Tunis, Tunisia), H. Aoudani (Tunis, Tunisia), S. Cheik Rouhou (Tunis, Tunisia), S. Merai (Tunis, Tunisia), M. Sellami (Tunis, Tunisia), S. Toujani (Tunis, Tunisia), B. Dhahri (Tunis, Tunisia)
Source: Virtual Congress 2021 – Management of chronic cough and obstructive diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Mjid (Tunis, Tunisia), L. Laadhar (Tunis, Tunisia), A. Taboubi (Tunis, Tunisia), I. Ayadi (Tunis, Tunisia), A. Hedhli (Tunis, Tunisia), Y. Ouahchi (Tunis, Tunisia), H. Aoudani (Tunis, Tunisia), S. Cheik Rouhou (Tunis, Tunisia), S. Merai (Tunis, Tunisia), M. Sellami (Tunis, Tunisia), S. Toujani (Tunis, Tunisia), B. Dhahri (Tunis, Tunisia). Receptor activator of nuclear factor-kB ligand (RANKL) and bone mineral density in Tunisian patients with chronic obstructive pulmonary disease (COPD). 1950
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: